South Carolina Research Studies Directory

A Phase IIa, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Assess the Efficacy, Safety, and Tolerability of AZD4144 in Participants with Sepsis-associated Acute Kidney Injury

Date Added
April 15th, 2026
PRO Number
Pro00148577
Researcher
Nicolas Pope

List of Studies

Keywords
Critical Care
Summary

The purpose of this research is to look at the safety and tolerabilty of an experimental study drug called AZD4144 and its effect on Sepsis-Associated Acute Kidney Injury (SA-AKI). The main goal of this research is to compare specific kidney function measurements between those participants receiving AZD4144 and those receiving the placebo.

Institution
MUSC
Recruitment Contact
Morgan Overstreet
(843) 792-8896
overstrm@musc.edu



-- OR --